A single-dose oral medication called zoliflodacin shows promise as a new treatment for antibiotic-resistant gonorrhea, according to a Phase III trial published in The Lancet.
This article was originally published on MedicalXpress.com
Single-dose oral treatment for gonorrhea effectively combats drug-resistant infections, clinical trial finds
You may also be interested in:
The Latest
Setting Boundaries: Nurturing a Healthy Partnership
What Are Boundaries? As the word portrays, boundaries in a relationship help each person establish expectations with their partner. Boundaries can help you communicate what you are comfortable with and what you are willing to […]
The Latest
Will a nutritional supplement help you run better?
Whether you jog to keep fit or compete in marathons, the physically demanding sport of running can deplete the body of essential nutrients. During a race like a half-marathon, a runner’s metabolism — or ability […]
The Latest
The Key to a Strong Relationship? Communication
Effective communication is the foundation of any strong, healthy relationship. This article will explore the key elements required to build better communication between partners. We’ll cover the importance of active listening, using empathy and understanding […]
Read More:
-
It’s common that as kids get to high school and transition to adulthood, they begin to skip yearly wellness visits with a pediatrician or other [...]
-
In 2024, 31.7% of adults and 29.5% of children had a diagnosed seasonal allergy, diagnosed eczema, or a diagnosed food allergy in the United States, [...]
-
U.S.-born individuals have higher odds of infant mortality than non-U.S.-born individuals, according to a study published online Jan. 6 in JAMA Network Open.This article was [...]
